chrisvoncsefalvay/vaers-outcomes huggingface dataset:
tested positive for SARS CoV 2; tested positive for SARS CoV 2; Dose 1: Moderna: Dose 2: Moderna, Dose 3 Brand: Pfizer; This is a spontaneous report received from a contactable reporter(s) (Physician) from regulatory authority. The reporter is the patient.  A 43 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administration date 28Oct2021 (Lot number: 30155BA) at the age of 43 years as dose 3 (booster), single for covid-19 immunisation; covid-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), administration date 09Feb2021 (Lot number: 032L20A) as dose 2, single and administration date 12Jan2021 (Lot number: 011L20A) as dose 1, single for covid-19 immunisation. Relevant medical history included: "migraines" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant) with onset 23Jan2022, outcome "unknown", COVID-19 (medically significant) with onset 24Jan2022, outcome "not recovered" and all described as "tested positive for SARS CoV 2"; INTERCHANGE OF VACCINE PRODUCTS (non-serious) with onset 28Oct2021, outcome "unknown", described as "Dose 1: Moderna: Dose 2: Moderna, Dose 3 Brand: Pfizer". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (24Jan2022) positive, notes: Nasal Swab; (22Jan2022) negative, notes: Nasal Swab. Therapeutic measures were not taken as a result of covid-19. The patient not had a covid prior to the vaccination and tested for covid post vaccination.
runny nose that had bloody discharge; runny nose that had bloody discharge; The mother was 23 weeks pregnant at the onset of the event; pregnancy; pregnancy; This is a spontaneous report from a non-contactable physician (patient). A 36-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: Not available/provided to reporter at the time of report completion) via an unspecified route of administration on 26Dec2020 13:30 on right arm at a single dose for COVID-19 immunization. The patient was allergies for adhesives. The patient is pregnant at the time of vaccination. The mother was 23 weeks pregnant at the onset of the event. The mother was due to deliver on 23Apr2021. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. Concomitant medication included acetylsalicylic acid (ASPIRIN 81) at 81mg. The patient experienced runny nose that had bloody discharge on 27Dec2020. No treatment received for the event. The outcome of the event was recovered in Dec2020.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Patient reported to pharmacy on 10/10/17 that she had adverse reaction to vaccines given on 10/03/17. Patient stated she had swollen eyes and felt like she was going to vomit the following day (10/04/17). She stated that her blood pressure was elevated and had to take extra medication to get it to return to normal limits. Patient stated that several times during the day she felt the need to have her spouse drive her to the hospital but never went and eventually had all symptoms stop and her blood pressure return after a few days.
Nauseous; I am not feeling so good; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 24Sep2021 09:30 (Lot number: FA6780) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NAUSEA (non-serious) with onset 24Sep2021, outcome "unknown", described as "Nauseous"; MALAISE (non-serious) with onset 24Sep2021, outcome "unknown", described as "I am not feeling so good".  No follow-up attempts are possible. No further information is expected.
Developed redness and swelling on two separate spots on right arm (around and tricep area) about 24 hrs after immunization given
9/3/2021- Left arm starting aching again from injection site to left wrist, rash around injection site (2-3 days) 9/10/2021-Left arm injection area rash again, red, warm and swollen, hard time catching breath, dizziness (2-3 days)Dr ran blood tests and D Dimer came back abnormal, was sent to ER for CT scan to check for pulmonary embolism. CT scan was not done due to technical issue at the hospital. Was given IV fluids and was told to come back if I had any chest pain or symptoms got worse. 9/17/2021- Left arm injection area rash again, red, warm and swollen 9/22/2021- Sever lower abdomen pain, diaherria, cold sweats, dizziness, nauseous 9/23/2021- Bloody stool, diaherria, Went to Gastrologists and did multiple fecal tests-all came back normal except for swelling in colon
01/03-07/2022 I was admitted into the hospital and had pneumonia in my left lung and pulmonary embolism in both lungs.
Breakthrough case admission after 2 vaccines Moderna 3/15/21 Lot# 030A21A;  Moderna 4/14/21 Lot# 043B21A
Information has been received from a physician concerning a 61 year old female with type ii diabetes mellitus, hypertension, hypercholesterolaemia, asthma, glucose, statin allergies, allergies to ezetimibe and glucophage who on 12-SEP-2007 at 14:00 was vaccinated S in the right arm with a 0.65 ml single dose of Zostavax (Lot#658211/0884U). Concomitant therapy included lisinopril-HCTZ, CENTRUM, GNC TRIFLEX, vitamin E, ALLEGRA, ADVAIR, SINGULAIR, NASONEX, AVANDIA. There was no illness at the time of vaccination. On 13-SEP-2007 the patient developed injection site erythema, pain, pruritus and swelling which persisted over several days. On the fourth day after administration the patient awoke with severe pain, erythema, swelling and loss of motion in the region of the right thumb. The symptoms were treated initially with indomethacin for possible  gout, but the erythema and inflammation increased. The patient was then administered an IM dose of ROCEPHIN as well as KEFLEX 500mg four times a day for 10 days. The patient was seen three times over the course of ten days and by day four of the antibiotic therapy the patient's symptoms had greatly improved. No lab studies were performed. At the time of this report the the patient had recovered. No further information was provided. There was no product quality complaint involved. Additional information has been requested. This patient also had adverse experiences after therapy with ezetimibe (WAES # 0710USA00821).
This spontaneous report was received from a medical assistant (healthcare worker) refers to multiple unspecified patients of unknown demographics. On an unknown dates, the patients were vaccinated with improperly stored VAQTA lot # M002268 with expiration date: 20-SEP-2017; lot # M017982 with expiration date: 13-SEP-2017; lot # M022924 with expiration date: 24-JAN-2018; (strength, dosage and route unspecified). Temperature excursion details are as follows: temperature of 53.2F for time frame of 4.75 hours (285 minutes). There was no previous temperature excursion. Call was because of a data logger. No adverse effect reported. No product quality complaint involved. No additional information available. This is one of several reports received from the same reporter. Additional information has been requested.
Day after had 101 temperature, headache, vomiting, soar throat, runny nose and body felt like glass. 4 days after and still fill pretty sixk
Pt. states that she woke up with headache, feeling feverish and rash on face. States was seen in ER on 9/30/12, because of headache and was given Valium.
11/15/22 presents to EC ED for "fall" "weakness, tiredness". PMHx of "CKD, CAD, and degenerative disc disease"
eyelid was itching; skin on the side of my eye was puffy/swollen; tiny hive above the eyelid; white rash just above the eyelid; 3-4 minutes after the shot my left eye felt "funny", right in the corner by the tear duct; This is a spontaneous report from a contactable consumer (patient) received via  portal. A 69-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in left arm on 25Feb2021 at 12:30 (Batch/Lot Number: EN6200) (at the age of 69-years-old) as dose 1, single for COVID-19 immunisation. Medical history included stroke on 2014; known allergies to Iodine Dye (allergic reaction to a contrast x-ray, where left eye "felt funny" and then face swelled up), Erythromycin, Sulphur Drugs, and surgical tape. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. Concomitant medications included apixaban (ELIQUIS); propranolol; ezetimibe; zolpidem; ergocalciferol (VIT D) and B12 (CYANOCOBALAMIN); all taken for an unspecified indication, start and stop dates were not reported. The patient did not receive any other vaccines within 4 weeks prior to COVID-19 vaccine. The patient experienced 3-4 minutes after the shot her left eye felt "funny", right in the corner by the tear duct on 25Feb2021; eyelid was itching and looking at her magnetized mirror the skin on the side of her eye was puffy/swollen just by the nose and it looked like a tiny hive or tiny white rash just above the eyelid where it was itching on 25Feb2021 at 12:30. The patient received no treatment for the events. The adverse events resulted to none. The outcome of events was not recovered.  No follow-up attempts are possible. No further information is expected.
while receiving the 2nd dose, syringed leaked some of it; the syringe leaked some of it; A spontaneous report  was received from a Pharmacist regarding a patient of unspecified age and gender who received second dose of Moderna's COVID-19 vaccine (mRNA-1273) and while receiving the second dose, the syringe leaked some of it (Incomplete dose administered/syringe leak).  The patient's medical history was not provided.  Concomitant medications were not provided.   On an unspecified date, prior to the onset of events, the patient received their second of two planned doses of mRNA-1273 for the prophylaxis of COVID-19 infection.   While receiving the vaccine, the syringe leaked and some of it came out.   Action taken with mRNA-1273 vaccine was not applicable as the patient received both planned doses.  The events were considered resolved.; Reporter's Comments: This report refers to a case of a patient of unspecified age and gender who experienced non-serious unexpected events the syringe leaked some of it (incomplete dose administered/ syringe leak) for mRNA-1273, lot # unknown. There were no reported AEs associated with this case of Incomplete dose administered.
Janssen COVID-19 Vaccine:  Vaccine administered by pharmacy staff at 1320, patient was observed for 15 minutes without complaint or concern.  Upon check-out he stated he was "starting to feel sweaty".  He denied dizziness, difficulty breathing, chest pain or other concerns.  Systolic blood pressure was 76/40 (manual), heart rate 70.  He remained awake, alert, skin pale,  clammy,  & cool.  Sweat noted on forehead, in no acute distress.  He was transferred to supine position and given cold water.  BP increased to 124/82, heart rate 88, pulse ox 98%.  He verbalized he felt much better, stated he began to have concerns about a reaction when he began to feel sweaty.  He was unsure if it was anxiety or a reaction to the vaccine as the feelings began to escalate.  He has no history of similar reactions but "doesn't like shots".    He has no medical history, takes no medications/supplements and is otherwise "healthy".  He ate lunch prior to appointment.  Additional BP readings remained within normal limits,  skin warm/dry, back to baseline.  Observed for an additional 45 minutes and returned to work.  Discharge vitals: 116/84, 90, 98%, 16.
Patient developed symptoms on 2/13/2021 with epistaxis.  Then developed blood blisters in mouth and petechiae over lower extremities.  Saw me on 2/16 and labs showed platelet count less than 3000.
Received 1st covid 19 vaccine Friday the 2nd, Saturday 4/3 he experienced dizziness, weakness, loss of balance, numbness, slurred speech, went to ED  Sunday morning, admitted to Med Surg floor 4/4/2021
Information regarding PREVNAR was received from a healthcare professional regarding a patient who experienced injection site pain. The patient received a dose on an unspecified date. Relevant medical history was not provided. Product was administered on an unspecified date. Dose regimen was 1 dose 1 time per day (intramuscular). Concomitant therapy included IPOL. A Physician reported approximately 10-15 patients experienced injection site pain and cried for approximately several minutes. The physician noted this had not happened before. The patient's outcome is unknown. No additional information was available at the time of this report.
Two (2) days after the Moderna Covid19 injection in my left are, it was red and swollen.  I still have terrible pain all through both arms.  It feels like pulled muscles with shots of electricity radiating through my body.  I am taking extra-strength Tylenol for the pain.
a friend of hers that died on 16Apr21; This is a spontaneous report received from a contactable consumer and downloaded from the Regulatory Authority, regulatory authority number ES-AEMPS-972586. This consumer reported for a 90-year-old male patient (friend) who received bnt162b2 (Formulation:Solution for injection, Batch/Lot number was not reported, Expiry date: unknown), via an unspecified route of administration on an unspecified date as dose number unknown, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. The consumer reported a friend of hers (patient) that died on 16Apr2021. He got his vaccine at the same time her husband did, but she is unsure if it was Pfizer. It was not reported if an autopsy was performed. The outcome of the event was fatal.  The lot number for the vaccine, (BNT162B2), was not provided and will be requested during follow up.; Reported Cause(s) of Death: She also mentioned a friend of hers that died on 16Apr2021.
muscle soreness & tightness in the jaw; 4MAY95 f/u: sx lasting 1 wk;no further complaints;history & exam negative;
Adverse event did not occur.  Reporting incident per company protocol.  Patient request bivalent covid vaccine and received monovalent covid vaccine.
Improper storage of product in use; no adverse event; This spontaneous report was received from a nurse referred to a patient of unknown age and gender. The patient's medical history, concurrent conditions, drug reactions/allergies and concomitant therapies were not reported.  On an unknown date, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 1 dose, lot #W031813, expiration date was not reported, but upon internal validation established as 05-OCT-2024, as prophylaxis (strength, and route of administration were not provided), while it had a temperature excursion (temperature 24.4 Fahrenheit (F) for time frame as 5 hours 51 minutes 0 seconds) (product storage error). There was no previous temperature excursion. No additional adverse event was reported (no adverse event). The patient was asymptomatic.
Dizziness, headache and tremor/ shakiness / body aches. Acetaminophen 650 mg once, Diphenhydramine 25 mg once.
Dizzy; Nauseous; tired; Diarrhea; Headache; Sore throat; cough; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore throat), COUGH (cough), DIARRHOEA (Diarrhea), DIZZINESS (Dizzy) and HEADACHE (Headache) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat) and COUGH (cough). On 26-Jan-2021, the patient experienced DIARRHOEA (Diarrhea) and HEADACHE (Headache). On 30-Jan-2021, the patient experienced DIZZINESS (Dizzy), NAUSEA (Nauseous) and FATIGUE (tired). On 26-Jan-2021, OROPHARYNGEAL PAIN (Sore throat) and COUGH (cough) had resolved. On 01-Feb-2021, DIARRHOEA (Diarrhea) had resolved. At the time of the report, DIZZINESS (Dizzy), HEADACHE (Headache), NAUSEA (Nauseous) and FATIGUE (tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included Mylanta.
Itching on my body and red marks on skin; Itching on my body and red marks on skin; This is a spontaneous report from a contactable consumer (patient). A non-pregnant female patient of an unspecified age (elderly 65+ years) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot/batch number was not reported) via an unspecified route of administration, administered in arm left on 06Mar2021 04:45 pm as dose 1, single for covid-19 immunisation. The patient had known allergies of her to mosquito bites. There was no other medical history reported. She had not tested for covid post vaccination. The concomitant medication included pravastatin sodium (PRAVASTIN), Lisinopril, temazepam, gabapentin. The patient experienced itching on her body and red marks on skin on 13Mar2021 12:00 AM. She did not receive treatment for adverse events. The outcome of events was recovered on an unknown date in 2021.  No follow-up attempts were possible. No further information was expected.
Pt reports headache for 5 days, fatigue, body aches, muscle aches.
Patient had heart palpitation, elevated blood pressure of 140-80, dizziness, nausea and vomitting.
Information has been received from a consumer concerning her now a 5 years old son who in approximately 2005 ("when he was 1 year old") was vaccinated with MMR II. The patient had what was determined by an allergist to be an "internal allergy" to the measles and mumps component of MMR II. The patient sought unspecified medical attention. The patient underwent numerous treatments and was on many medications to reverse the effects of this "allergic reaction" during past 4 years and is considered recovered now. Specific details of how the allergy manifested was not shared but consumer did mention her son displayed "OCD (obsessive compulsive disorder) habits". Specific of treatment was also not known. No further information is available.
After being vaccinated, Patient tested positive for COVID 19 5/10/21, with symptoms starting 5/8/21
No additional AE's/PQC's; Caller reporting a temperature excursion for frozen products/ Caller notes PROQUAD lots: U006313, T030760, and U002539 have been administered to patients, as well as V ARlV AX lot: U010401.; This spontaneous report was received from an unspecified reporter (also reported on physician's field) (conflicting information) referring to a patient with unknown age and gender. No information was provided regarding the patient's pertinent medical history, concomitant medications, past drug reactions or allergies.  On 11-AUG-2021, the frozen product Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live recombinant human albumin (rHA) (PROQUAD) (lot number U006313, was verified to be a valid lot number with an expiration date reported and established as 24-AUG-2022) experienced a temperature excursion of 7.2 degrees Fahrenheit (F) during a time frame of 56 minutes.  On 20-AUG-2021, the patient was vaccinated with this improperly stored Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live recombinant human albumin (rHA) (PROQUAD) at a dose/frequency reported as one (1) (units not provided) (concentration, exact dose, exact vaccination scheme frequency, route and anatomical site of administration were not reported) for prophylaxis (product storage error).  It was stated that no previous temperature excursion was reported. The reporter was unaware if the patient had experienced any symptoms after administration. No additional adverse events (AEs) were reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2109USA000271:
12 hrs post vaccine developed itching and hives that worsened over the next 2 days-self medicated with Benadryl. Saw MD on day 3 and was put on Prednisone x 2 wks. Condition immediately improved with prednisone and has now resolved. Plans to see allergiest before future flu shots.
Received immunization on 05/29/14 to right and left thigh. 5/30/14 Redness to injection site - rt thigh. 5/31/14 Redness to injection site grew - developed red line - rt thigh. 6/1/14 Redness to injection site rt thigh worse - Developed another red line, hard, painful, inflamed. Treated for cellulitis with AUGMENTIN/ORAPRED.
pt has inc number of sz from 1 per month to twice a week;change of sz also noted;happens now when is awoke while it used to happen only when asleep;pt being followed by neuro;
Plenty rashes from the left knee down to the ankle , front part and also the back side .same for the right knee not as bad as the left .; Energy levels have decrease since the injection for no reason; Dose number=4; Administration date=31Mar2022 and Other Vaccine same date dose number=3; Other Vaccine same date vaccine date=31Mar2022; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53-year-old male patient received BNT162b2 (BNT162B2), on 31Mar2022 as dose 3 (booster), single (Batch/Lot number: unknown) and on 31Mar2022 at 17:00 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 54 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing). The patient took concomitant medications. Vaccination history included: Covid-19 vaccine (Primary immunization series complete but unknown manufacturer.), for Covid-19 immunization. The following information was reported: INCORRECT DOSE ADMINISTERED (non-serious) with onset 31Mar2022, outcome "unknown", described as "Dose number=4; Administration date=31Mar2022 and Other Vaccine same date dose number=3; Other Vaccine same date vaccine date=31Mar2022"; ASTHENIA (non-serious) with onset 02Apr2022 at 07:00, outcome "not recovered", described as "Energy levels have decrease since the injection for no reason"; RASH (non-serious) with onset 02Apr2022 at 07:00, outcome "not recovered", described as "Plenty rashes from the left knee down to the ankle , front part and also the back side .same for the right knee not as bad as the left .". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of rash, asthenia.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
I didn't realize until yesterday that my symptoms could be related to my vaccine but, Sunday morning 3/6 I woke up and both my hands felt achy, it got worse over the morning  ( 6 out of 10 on the pain scale) so I took Tylenol 650 mg, and rubbed CBD cream on them. It helped but the ache ( which feels like severe arthritis) came back in the evening. This has been continuous since Saturday morning. Both hands and mostly aches in the thumbs and wrists migrating up into my forearms. I continue to take the Tylenol BID. The Tylenol controls it for a while. Today the ache is lessened some ( maybe 4-5 out of 10 on the pain scale). I have not contacted my Physician. I've had no fever or other problems, just this achy, arthritis feeling in my hands and forearms.